At present, the pneumonia caused by the novel coronavirus (2019-nCoV) infection has developed into a serious public health problem. In vitro studies and clinical treatment have shown that arbidol has anti-2019-nCoV activity, which attracted much attention. Arbidol is a small molecule indole derivative developed by the former Soviet Union, which was approved for the prevention and control of Flu-A and Flu-B. Recent studies have found that arbidol has antiviral activity against a variety of viruses. Because of its unique antiviral effect, it provides a new breakthrough for antiviral therapy. For this reason, this article reviews the progress of antiviral research on arbidol.

arbidol  /  anti-vital treatment  /  progress in researches  /  SARS-CoV-2